Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Dussol

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Kidney International|October 2, 2004
Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantationBertrand Dussol, Jean-Louis Bonnet, Jerome Sampol, et al.
Orphanet Journal of Rare Diseases|December 6, 2019
Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs QuestionnaireEsther Noël, Bertrand Dussol, Didier Lacombe, et al.
Nephrologie & Therapeutique|September 30, 2017
[Uro- and nephrotoxic effects of drugs of abuse: Literature review and pharmaco-epidemiological survey in France and in the Marseille area]Marion Gully, Élisabeth Frauger, Michel Spadari, et al.
Journal of the American Society of Nephrology : JASN|December 24, 2011
Correction of postkidney transplant anemia reduces progression of allograft nephropathyGabriel Choukroun, Nassim Kamar, Bertrand Dussol, et al.
Circulation|November 4, 2017
Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft VasculopathyPascale Paul, Christophe Picard, Emmanuelle Sampol, et al.
Journal of Clinical Medicine|March 10, 2022
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry DiseaseWladimir Mauhin, Abdellah Tebani, Damien Amelin, et al.
Retrovirology|April 3, 2016
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trialErwann P Loret, Albert Darque, Elisabeth Jouve, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 2008
Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trialBertrand Dussol, Sophie Morange, Stéphane Burtey, et al.
BMC Nephrology|November 3, 2021
Kidney biopsy in very elderly patients: indications, therapeutic impact and complicationsMathilde Fedi, Mickaël Bobot, Julia Torrents, et al.
Medicine|June 4, 2016
Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven GlomerulonephritisPierre-Andre Jarrot, Laurent Chiche, Baptiste Hervier, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Kidney International|October 2, 2004
Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantationBertrand Dussol, Jean-Louis Bonnet, Jerome Sampol, et al.
Orphanet Journal of Rare Diseases|December 6, 2019
Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs QuestionnaireEsther Noël, Bertrand Dussol, Didier Lacombe, et al.
Nephrologie & Therapeutique|September 30, 2017
[Uro- and nephrotoxic effects of drugs of abuse: Literature review and pharmaco-epidemiological survey in France and in the Marseille area]Marion Gully, Élisabeth Frauger, Michel Spadari, et al.
Journal of the American Society of Nephrology : JASN|December 24, 2011
Correction of postkidney transplant anemia reduces progression of allograft nephropathyGabriel Choukroun, Nassim Kamar, Bertrand Dussol, et al.
Circulation|November 4, 2017
Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft VasculopathyPascale Paul, Christophe Picard, Emmanuelle Sampol, et al.
Journal of Clinical Medicine|March 10, 2022
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry DiseaseWladimir Mauhin, Abdellah Tebani, Damien Amelin, et al.
Retrovirology|April 3, 2016
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trialErwann P Loret, Albert Darque, Elisabeth Jouve, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 2008
Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trialBertrand Dussol, Sophie Morange, Stéphane Burtey, et al.
BMC Nephrology|November 3, 2021
Kidney biopsy in very elderly patients: indications, therapeutic impact and complicationsMathilde Fedi, Mickaël Bobot, Julia Torrents, et al.
Medicine|June 4, 2016
Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven GlomerulonephritisPierre-Andre Jarrot, Laurent Chiche, Baptiste Hervier, et al.
Pageof 10